|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500110444 |
|
最近更新日期: Date of Last Refreshed on: |
2025-10-14 10:13:43 |
|
注册时间: Date of Registration: |
2025-10-14 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
脑卒中患者社会功能康复的移动交互式干预效果研究:一项随机对照试验 |
|
Public title: |
Effect of Mobile Interactive Intervention on Social Function Rehabilitation in Stroke Survivors: A Randomized Controlled Trial |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
脑卒中患者社会功能康复的移动交互式干预效果研究 |
|
Scientific title: |
Effect of Mobile Interactive Intervention on Social Function Rehabilitation in Stroke Survivors |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
周璇 |
研究负责人: |
周璇 |
|
Applicant: |
Xuan Zhou |
Study leader: |
Xuan Zhou |
|
申请注册联系人电话: Applicant telephone: |
+86 21 8187 1527 |
研究负责人电话: Study leader's telephone: |
+86 157 2157 0098 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
m15721570098@163.com |
研究负责人电子邮件: Study leader's E-mail: |
m15721570098@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市杨浦区翔殷路800号 |
研究负责人通讯地址: |
上海市杨浦区翔殷路800号 |
|
Applicant address: |
800 Xiangyin Road, Yangpu District, Shanghai |
Study leader's address: |
800 Xiangyin Road, Yangpu District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
海军军医大学 |
||
|
Applicant's institution: |
Naval Medical University |
||
|
研究负责人所在单位: |
上海市第一康复医院 |
||
|
Affiliation of the Leader: |
Shanghai First Rehabilitation Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
YK-2025-03-011 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市第一康复医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Shanghai First Rehabilitation Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-08-28 00:00:00 |
||
|
伦理委员会联系人: |
叶成林 |
||
|
Contact Name of the ethic committee: |
Ye Chenglin |
||
|
伦理委员会联系地址: |
上海市杨浦区杭州路349号 |
||
|
Contact Address of the ethic committee: |
349 Hangzhou Road, Yangpu District, Shanghai, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 6543 2021 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海市第一康复医院 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Shanghai First Rehabilitation Hospital |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市杨浦区翔殷路800号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
800 Xiangyin Road, Yangpu District, Shanghai |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金青年科学基金项目(82202816) |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Youth Science Fund Project of the National Natural Science Foundation of China (82202816) |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Stroke |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
探究基于心理弹性的脑卒中移动交互式系统对改善脑卒中患者社会参与的实际效果。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
To investigate the effect of the resilience-based digital intervention on improving social participation in stroke survivors with limb dysfunction. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
1.符合第四届全国脑血管病会议制定的脑卒中诊断标准的患者,包括缺血性脑卒中和出血性脑卒中; 2.最后一次脑卒中发病的病程 ≥ 3个月; 3.年龄介于18至80周岁; 4.存在肢体功能障碍,且改良Rankin量表(modified Rankin Scale, mRS)评分为1-4分; 5.生命体征平稳者; 6.蒙特利尔认知评估量表(Montreal Cognitive Assessment,MoCA)得分 ≥ 26分,提示认知功能正常; 7.无明显的听觉或语言交流障碍; 8.自愿参与研究,并签署知情同意书。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
1. Patients who meet the diagnostic criteria for stroke (including both ischemic and hemorrhagic stroke) as defined by the Fourth National Cerebrovascular Disease Conference. 2. Patients with a disease duration of >=3 months since the last stroke onset. 3. Aged between 18 and 80 years. 4. Presence of limb dysfunction, with a modified Rankin Scale (mRS) score between 1 and 4. 5. Stable vital signs. 6. A score of >= 26 on the Montreal Cognitive Assessment (MoCA), indicating normal cognitive function. 7. No significant auditory or linguistic communication barriers. 8. Voluntary participation in the study with a signed informed consent form. |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1. 无法使用智能手机或完成数字化干预者; 2. 患有可能混淆研究结果的合并症(例如:严重吞咽障碍、重度抑郁症、晚期癌症、重要器官功能衰竭等); 3. 同时参与其他临床试验者; 4. 经研究者判断,存在任何其他可能影响研究依从性或安全性的情况。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
1. Inability to use a smartphone or complete digital interventions. 2. Comorbid conditions that could confound outcomes (e.g., severe dysphagia, major depressive disorder, advanced cancer, end-stage organ failure). 3. Participation in another concurrent clinical trial. 4. Any other reason considered by the investigators to affect compliance or safety. |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-10-20 00:00:00至 To 2026-05-20 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-10-20 00:00:00 至 To 2025-12-20 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
受试者将被随机分配至干预组或对照组。随机序列将由独立师通过计算机随机数字生成器产生。为确保受试者特征在组间均衡分布,将按康复病区进行分层随机,采用区组大小为6的区组随机化法。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Participants will be randomly allocated to either the intervention or control group. The randomization sequence will be generated by an independent statistician using a computer-based random number generator. To ensure balanced distribution of participants’ characteristics across groups, the randomization will be stratified by rehabilitation wards with a block size of six. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
鉴于干预措施的性质,本研究采用单盲设计。干预人员和参与者无法对分组情况不知情。负责收集基线和随访数据的研究人员将对参与者的分组情况不知情。 |
|
Blinding: |
This study is single-blinded in view of the nature of the intervention. intervention staff and participants are not feasible to be blinded to the group allocation. The researcher collecting baseline and follow-up data will be kept blind to participant allocation. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
NA |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
所有参与者的数据将首先在评估现场使用标准化的纸质病例报告表进行采集,随后转录至中央电子数据库。为保障数据准确性,将采用双人双录入模式并实施逻辑性与范围校验。所有数据均通过唯一研究编码进行去标识化处理,存储于受密码保护的安全服务器中,仅研究团队成员具备访问权限。在研究完成且所有数据经核查确认无误后,电子数据库将在主要研究者的指导下正式锁定。该锁定数据集将作为本研究所有最终分析的权威依据。主要研究者及研究团队将负责持续的安全监测,包括系统性收集、记录和评估所有不良事件。任何严重不良事件均将在规定时限内向机构审查委员会报告。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data from all participants will be initially collected using standardized paper-based Case Report Forms (CRFs) at the assessment sites. These data will be subsequently transcribed into a centralized electronic database. A double-data entry process with built-in logical and range checks will be employed to ensure accuracy. All data will be de-identified using unique study codes and stored on secure, password-protected servers. Only the research team will have access to the servers. Upon study completion and after all data have been verified for accuracy, the electronic database will be formally locked under the instruction of the Principal Investigator. This locked dataset will serve as the definitive basis for all final analyses in this study. The Principal Investigator and the research team will be responsible for continuous safety monitoring. This includes the systematic collection, documentation, and assessment of all adverse events. Any serious adverse events will be reported to the Institutional Review Board within the required timeframe.,.,.,,.,..,.. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |